AMRX compared with JXN: revenue, margins and what each company keeps, and the suppliers and customers both name

AMRXAmneal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

JXNJackson Financial Inc.

Mkt capRevenueRevenue

Compare

AMRXAmneal Pharmaceuticals, Inc.

JXNJackson Financial Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMRX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 3 '26thin chain±22.7%▼−1.13%×0.05

Q2 FY26±15.6%▼−3.14%×0.20

May 8 '26±10.1%▼−3.79%×0.38

Q1 FY26±21.3%▼−1.54%×0.07

JXN

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±8.1%▼−2.35%×0.30

Q2 FY26±8.5%▲+5.90%×0.69

= impliedAMRX realized, solidJXN realized, hatchedOne scale, both sides: full bar = 23%× = |realized| ÷ impliedSource: market data

Q1 FY26

±7.4%

▲+5.93%

×0.80

Feb 19 '26±6.9%▼−2.73%×0.39

AMRXAmneal Pharmaceuticals, Inc.

20.13▲+3.52%· post 20.40

Mkt cap$6.4BRevenue$796MQ2 FY26Revenue$3.0BFY25

JXNJackson Financial Inc.

132.32▼−0.31%· post 132.14

ClosedNov 6 '26

Mkt cap$8.7BRevenue$2.8BQ3 FY26Revenue$10.5BFY25

Compare

ClosedNov 6 '26

AMRXAmneal Pharmaceuticals, Inc.

JXNJackson Financial Inc.

20.13▲+3.52%post 20.40

Price

132.32▼−0.31%post 132.14

$6.4B

Mkt cap

$8.7B

Q2 FY26$796M

Revenue

$2.8BQ3 FY26

FY25$3.0B

Revenue

$10.5BFY25

AMRX20.13▲+3.52%vsJXN132.32▼−0.31%ClosedNov 6 '26